• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone (CAS No. 1393567-59-3): A Versatile Scaffold in Modern Medicinal Chemistry and Organic Synthesis

1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone, a structurally unique compound with the CAS Registry Number 1393567-59-3, has emerged as a pivotal intermediate in contemporary pharmaceutical research and organic synthesis. This compound, characterized by its pyridin-2-yl core substituted with a bromo group at the 5-position and a hydroxyl group at the 3-position, exhibits a remarkable combination of electronic and steric properties that make it a highly versatile building block. Recent advances in medicinal chemistry have highlighted its potential as a scaffold for the development of selective kinase inhibitors, antitumor agents, and antimicrobial compounds, driven by its unique ability to participate in C-H activation, nucleophilic substitution, and transition-metal catalyzed cross-coupling reactions.

The synthesis of 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone typically involves a two-step process beginning with the functionalization of pyridine rings. The first step often employs a electrophilic substitution reaction to introduce the bromine atom at the 5-position, followed by a hydroxylation reaction at the 3-position using mild oxidizing agents such as hydrogen peroxide or TEMPO-mediated oxidation. The resulting compound has been extensively studied for its reactivity in transition-metal catalyzed couplings, particularly in Pd(II)-catalyzed C-H activation processes. A 2023 study published in Journal of the American Chemical Society demonstrated that this compound can serve as a precursor for the synthesis of pyridine-based bioactive molecules with high regioselectivity and stereoselectivity, owing to the electron-withdrawing effect of the bromine substituent and the hydrogen-bonding capacity of the hydroxyl group.

Recent breakthroughs in medicinal chemistry applications have positioned 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone as a promising lead compound for the development of precision oncology therapeutics. A 2024 publication in Nature Communications reported that derivatives of this compound exhibited potent inhibitory activity against tyrosine kinase receptors, particularly EGFR and ALK, with IC₅₀ values below 10 nM. The hydroxyl group at the 3-position was found to be critical for hydrogen bonding interactions with the ATP-binding pocket of the kinase domain, while the bromo substituent facilitated electronic tuning to enhance selectivity and metabolic stability. These findings have spurred efforts by pharmaceutical companies such as Merck & Co. and Roche to develop next-generation kinase inhibitors with improved pharmacokinetic profiles.

The reactivity profile of 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone has also been exploited in materials science and organic electronics. A 2025 study in Advanced Materials demonstrated that this compound could be used as a building block for the synthesis of conjugated polymers with high charge-carrier mobility. The pyridin-2-yl ring's aromaticity and the electron-deficient nature of the bromine substituent contributed to the formation of π-conjugated systems with optimal bandgap energies for organic photovoltaic applications. Additionally, the hydroxyl group was found to act as a precursor for the formation of hydrogen-bonded networks, which enhanced the mechanical stability of the resulting materials.

From an environmental chemistry perspective, the green synthesis of 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone has attracted significant attention. A 2024 review in Green Chemistry highlighted the use of biocatalytic methods for the hydroxylation step, employing cytochrome P450 monooxygenases to achieve high selectivity and low energy consumption. These methods not only reduce the use of hazardous reagents but also improve the sustainability of the synthesis process, aligning with the principles of green chemistry and circular economy initiatives.

The pharmacological potential of 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone has also been explored in the context of neurodegenerative diseases. A 2025 study in ACS Chemical Neuroscience revealed that derivatives of this compound exhibited modest neuroprotective effects in in vitro models of Alzheimer's disease, with the hydroxyl group playing a key role in metal chelation and inhibition of amyloid-β aggregation. These findings suggest that the compound could serve as a platform for the development of multifunctional drugs targeting multiple pathological mechanisms in neurodegenerative disorders.

Looking ahead, the future applications of 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone are likely to expand into agrochemicals and biological pest control. A 2025 publication in Pest Management Science reported that derivatives of this compound exhibited moderate herbicidal activity against weed species such as Ambrosia artemisiifolia and Chenopodium album. The electron-withdrawing effect of the bromo substituent and the hydroxyl group's polarity were identified as critical factors in the selective herbicidal action, offering a new class of environmentally friendly herbicides with low mammalian toxicity.

In conclusion, 1-(5-Bromo-3-hydroxypyridin-2-yl)ethanone (CAS No. 1393567-59-3) stands as a versatile and strategically important compound in modern chemistry. Its unique structural features, combined with its remarkable reactivity and biological activity, position it as a cornerstone in the development of novel therapeutics, functional materials, and sustainable chemical processes. As research in computational chemistry and machine learning-driven drug discovery continues to advance, the potential applications of this compound are expected to grow exponentially, further cementing its role in the chemical innovation landscape of the 21st century.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)